JP Morgan Chase
STIM icon

JP Morgan Chase’s Neuronetics STIM Stock Holding History

JP Morgan Chase’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.2K Buy
21,429
+4,853
+29% +$7.69K ﹤0.01% 6437
2025
Q4 		$22.9K Buy
16,576
+1,870
+13% +$3.91K ﹤0.01% 6470
2025
Q3 		$40.1K Sell
14,706
-51,636
-78% -$183K ﹤0.01% 6303
2025
Q2 		$232K Buy
66,342
+66,308
+195,024% +$262K ﹤0.01% 5164
2025
Q1 		$125 Sell
34
-54,905
-100% -$200K ﹤0.01% 6855
2024
Q4 		$88.5K Buy
54,939
+54,442
+10,954% +$56.6K ﹤0.01% 5799
2024
Q3 		$378 Sell
497
-3,715
-88% -$4.88K ﹤0.01% 6827
2024
Q2 		$7.58K Buy
4,212
+4,178
+12,288% +$12.1K ﹤0.01% 6310
2024
Q1 		$162 Sell
34
-654
-95% -$2.3K ﹤0.01% 6836
2023
Q4 		$2K Buy
688
+635
+1,198% +$1K ﹤0.01% 6721
2023
Q3 		$72 Sell
53
-1,137
-96% -$1.99K ﹤0.01% 6951
2023
Q2 		$2.56K Sell
1,190
-15,912
-93% -$38.6K ﹤0.01% 6297
2023
Q1 		$50K Buy
17,102
+7,749
+83% +$39.1K ﹤0.01% 5696
2022
Q4 		$64K Buy
9,353
+1,394
+18% +$6.58K ﹤0.01% 5527
2022
Q3 		$25K Buy
7,959
+4,379
+122% +$15.9K ﹤0.01% 5748
2022
Q2 		$11K Sell
3,580
-8,421
-70% -$24.4K ﹤0.01% 6017
2022
Q1 		$36K Sell
12,001
-11,199
-48% -$37.9K ﹤0.01% 5910
2021
Q4 		$104K Buy
23,200
+13,358
+136% +$65.4K ﹤0.01% 5665
2021
Q3 		$64K Buy
9,842
+237
+2% +$2.27K ﹤0.01% 5751
2021
Q2 		$154K Buy
9,605
+9,589
+59,931% +$132K ﹤0.01% 5364
2021
Q1 		$0 Hold
16
– – ﹤0.01% 6341
2020
Q4 		$0 Hold
16
– – ﹤0.01% 5917
2020
Q3 		$0 Sell
16
-43,316
-100% -$164K ﹤0.01% 5757
2020
Q2 		$84K Sell
43,332
-149,267
-78% -$306K ﹤0.01% 4644
2020
Q1 		$364K Buy
192,599
+46,685
+32% +$146K ﹤0.01% 3985
2019
Q4 		$655K Buy
145,914
+51,844
+55% +$322K ﹤0.01% 4102
2019
Q3 		$782K Buy
94,070
+6,501
+7% +$71K ﹤0.01% 3973
2019
Q2 		$957K Sell
87,569
-10,902
-11% -$154K ﹤0.01% 3899
2019
Q1 		$1.5M Buy
98,471
+51,143
+108% +$846K ﹤0.01% 3532
2018
Q4 		$916K Buy
47,328
+45,849
+3,100% +$1.01M ﹤0.01% 3795
2018
Q3 		$47K Buy
+1,479
New +$45K ﹤0.01% 5219

Other funds holding STIM

MAM
Madryn Asset Management New York $34.1M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase's STIM Position: Q1 2026 in Review

JP Morgan Chase increased its Neuronetics (STIM) stake by 29% in Q1 2026, buying an estimated $7.69K and bringing the position to 21,429 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6437.

JP Morgan Chase first reported a position in STIM in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.5M in Q1 2019. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • JP Morgan Chase held 21,429 shares of Neuronetics worth $27.2K as of Q1 2026.
  • JP Morgan Chase bought 4,853 Neuronetics shares in Q1 2026, an estimated $7.69K.
  • Neuronetics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6437 holding.
  • JP Morgan Chase first reported a position in Neuronetics in Q3 2018 and has held it in 31 quarters since.
  • JP Morgan Chase's Neuronetics position peaked at $1.5M in Q1 2019.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.